Dutch GPs call for ban on Novartis productsBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7360.355 (Published 17 August 2002) Cite this as: BMJ 2002;325:355
- Tony Sheldon
Three Dutch GPs are calling on doctors not to prescribe Novartis products in protest at the Swiss based pharmaceutical company's “information campaign” urging people with onychomycosis, or ringworm of the nails, to visit their GP.
In a row reflecting concerns across Europe, Dutch doctors and the government's advertising code commission had criticised the Novartis campaign, claiming that it promotes the company's prescription only product terbinafine (Lamisil). The Dutch Society of General Practitioners shares the concern that such information campaigns are an unnecessary burden, threatening the efficiency of prescribing and focusing attention on unimportant …
Log in using your username and password
Log in through your institution
Sign up for a free trial